Wendel (0HZD)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 82.65 |
|---|---|
| 52-week range | 72.65 – 91.50 |
| Return, 1 month / 3 months | −1.3% / +2.6% |
| Return, 1 year / 3 years | +10.5% / +34.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 57 |
| Volatility (1 year) | 23.4% |
| Worst drawdown (1 year) | -18.7% |
| Average daily value traded | 0.25M EUR |
| Dividend yield | 6.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wendel is a French investment company based in Paris that holds long-term stakes in businesses across several industries. Through its holdings it has interests in testing and inspection services, chemicals and coatings, and other industrial and service companies. Wendel acts as a patient owner, backing management teams and supporting the development of the firms in its portfolio over many years. Its investments span Europe and North America, and it operates as a family-controlled holding company.
Wendel trades under the code 0HZD on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wendel (0HZD) trades on the London Exchange in UK. It last closed at EUR 82.65 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,248 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.5% and over the last three months it rose 2.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.9% | ||
| From 52-week high | -9.6% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.6% | ||
| 6-month return | 2.3% | ||
| 12-month return, skipping the last month | 12.0% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.7% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.25M EUR | ||
| Zero-volume days | 10.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | −1.3% |
| 3 months | +2.6% |
| 6 months | +2.3% |
| 1 year | +10.5% |
| 3 years | +34.9% |
| 5 years | −9.9% |
Signals
| 50-day / 200-day average | 83.10 / 81.89 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | EUR 3.6000 |
| 18 Nov 2025 | EUR 1.5000 |
| 21 May 2025 | EUR 4.7000 |
| 21 May 2024 | EUR 4.0000 |
| 19 Jun 2023 | EUR 3.2000 |
| 20 Jun 2022 | EUR 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.